Seres Therapeutics (MCRB) Stock Price Target 2026

The average analyst price target for Seres Therapeutics is $13.75, 663.9% above the current price. Of 5 analysts, 2 rate it Buy, 1 Hold and 2 Sell. Targets range from $6 to $22. The latest change came on Jun 23, 2026, when HC Wainwright & Co. initiated coverage of Seres Therapeutics with a Buy rating and a $12 price target.